Neutrophil hitchhiking for nanoparticle delivery to the central nervous system DOI
Qingshan Liu,

Xuyan Li,

Yili Wang

et al.

Applied Materials Today, Journal Year: 2024, Volume and Issue: 38, P. 102259 - 102259

Published: May 25, 2024

Language: Английский

Neutrophil hitchhiking nanoparticles enhance bacteria-mediated cancer therapy via NETosis reprogramming DOI

Yuzhen Zhao,

Mingge Li,

Yue Guo

et al.

Journal of Controlled Release, Journal Year: 2024, Volume and Issue: 367, P. 661 - 675

Published: Feb. 8, 2024

Language: Английский

Citations

7
Nanodrug-bacteria conjugates-mediated oncogenic collagen depletion enhances immune checkpoint blockade therapy against pancreatic cancer DOI
Zhaoting Li,

Fanyi Mo,

Kai Guo

et al.

Med, Journal Year: 2024, Volume and Issue: 5(4), P. 348 - 367.e7

Published: March 22, 2024

Language: Английский

Citations

7
Progress of nanoparticle drug delivery system for the treatment of glioma DOI Creative Commons

Guogang Lai,

Hao Wu,

Kaixia Yang

et al.

Frontiers in Bioengineering and Biotechnology, Journal Year: 2024, Volume and Issue: 12

Published: June 11, 2024

Gliomas are typical malignant brain tumours affecting a wide population worldwide. Operation, as the common treatment for gliomas, is always accompanied by postoperative drug chemotherapy, but cannot cure patients. The main challenges chemotherapeutic drugs have low blood-brain barrier passage rate and lot of serious adverse effects, meanwhile, they difficulty targeting glioma issues. Nowadays, emergence nanoparticles (NPs) delivery systems (NDDS) has provided new promising approach gliomas owing to their excellent biodegradability, high stability, good biocompatibility, toxicity, minimal effects. Herein, we reviewed types mechanisms NPs currently used in including passive active delivery. In particular, primarily focused on various hopeful (such liposome, chitosan, ferritin, graphene oxide, silica nanoparticle, nanogel, neutrophil, adeno-associated virus), discussed advantages, disadvantages, progress preclinical trials. Moreover, outlined clinical trials applied gliomas. According this review, provide an outlook prospects NDDS treating summarise some methods that can enhance specificity safety NPs, like surface modification conjugating ligands peptides. Although there still limitations these will offer potential curing

Language: Английский

Citations

7
Reprogramming monocytes into M2 macrophages as living drug depots to enhance treatment of myocardial ischemia-reperfusion injury DOI
Yan Liu, Meiling Zhou,

Maochang Xu

et al.

Journal of Controlled Release, Journal Year: 2024, Volume and Issue: 374, P. 639 - 652

Published: Sept. 4, 2024

Language: Английский

Citations

7
Neutrophil hitchhiking for nanoparticle delivery to the central nervous system DOI
Qingshan Liu,

Xuyan Li,

Yili Wang

et al.

Applied Materials Today, Journal Year: 2024, Volume and Issue: 38, P. 102259 - 102259

Published: May 25, 2024

Language: Английский

Citations

6